title: Hemizygous/homozygous and heterozygous JAK2 mutation detected in plasma of patients with myeloproliferative diseases: correlation with clinical behaviour.
authors.forename: W
authors.initials: W
authors.lastname: Ma
authors.forename: H
authors.initials: H
authors.lastname: Kantarjian
authors.forename: S
authors.initials: S
authors.lastname: Verstovsek
authors.forename: I
authors.initials: I
authors.lastname: Jilani
authors.forename: M
authors.initials: M
authors.lastname: Gorre
authors.forename: F
authors.initials: F
authors.lastname: Giles
authors.forename: J
authors.initials: J
authors.lastname: Cortes
authors.forename: S
authors.initials: S
authors.lastname: O'Brien
authors.forename: M
authors.initials: M
authors.lastname: Keating
authors.forename: M
authors.initials: M
authors.lastname: Albitar
mesh_terms: D005838:Genotype; D006801:Humans; D053614:Janus Kinase 2; D009196:Myeloproliferative Disorders / Q000235:genetics* / Q000401:mortality; D017354:Point Mutation; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D015996:Survival Rate
chemical_list: D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2